Saruplase
Enzyme
N
Y (what is this?) (verify) Saruplase is a fibrinolytic enzyme.[1]
It is closely related to urokinase.[2]
References
- ^ Bär FW, Vermeer F, Michels R, et al. (1995). "Saruplase in Myocardial Infarction". J. Thromb. Thrombolysis. 2 (3): 195–204. doi:10.1007/BF01062710. PMID 10608024. S2CID 24046264.
- ^ Moser M, Bode C (March 1999). "Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction". Expert Opin Investig Drugs. 8 (3): 329–35. doi:10.1517/13543784.8.3.329. PMID 15992082.
External links
- Saruplase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- v
- t
- e
Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)
| Glycoprotein IIb/IIIa inhibitors |
|
|---|---|
| ADP receptor/P2Y12 inhibitors |
|
| Prostaglandin analogue (PGI2) | |
| COX inhibitors | |
| Thromboxane inhibitors | |
| Phosphodiesterase inhibitors | |
| Other |
| Vitamin K antagonists (inhibit II, VII, IX, X) | |||||
|---|---|---|---|---|---|
| Factor Xa inhibitors (with some II inhibition) |
| ||||
| Direct thrombin (IIa) inhibitors |
| ||||
| Other |
fibrinolytics
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
